Document

The unaudited pro forma condensed consolidated financial statements presented herein have been prepared in accordance with Article 11 of Regulation S-X and are based upon the Company’s audited consolidated financial statements for the year ended December 28, 2025 and the unaudited consolidated financial statements for the three months ended April 5, 2026 and certain assumptions, as set forth in the notes to unaudited pro forma condensed consolidated financial statements, that the Company believes are reasonable. The unaudited pro forma condensed consolidated balance sheet is presented as if the sale had been completed on April 5, 2026 and the unaudited pro forma condensed consolidated statements of operations are presented as if the sale had been completed on December 30, 2024. The pro forma adjustments presented herein are based on estimates and certain information that is currently available and may change as additional information becomes available. The unaudited pro forma condensed consolidated financial statements are not necessarily indicative of the results of operations or the financial position that would have resulted had the sale of China IDX been completed at the beginning of or as of the periods presented, nor is it indicative of the results of operations in future periods or the future financial position of the Company.


(In thousands)	Historical		Disposition and Pro Forma Adjustments			Pro Forma

Current assets:
Cash and cash equivalents	$	860,320	$	5,101	(a), (b)	$	865,421
Accounts receivable, net	691,380		(100,133)		(a)	591,247
Inventories, net	387,505		(6,694)		(a)	380,811
Other current assets	189,112		61,038		(a), (b)	250,150
Total current assets	2,128,317		(40,688)			2,087,629

Property, plant and equipment, net	465,636		(14,375)		(a)	451,261
Operating lease right-of-use assets, net	163,254		(4,462)		(a)	158,792
Intangible assets, net	2,306,534		(132,284)		(a)	2,174,250
Goodwill	6,610,750		(35,000)		(a)	6,575,750
Other assets, net	322,099		42,123		(a), (b)	364,222

Total assets	$	11,996,590	$	(184,686)	(a)	$	11,811,904

Current liabilities:
Current portion of long-term debt	$	575,831	$	—		$	575,831
Accounts payable	169,679		(5,635)		(a)	164,044
Accrued expenses and other current liabilities	493,134		1,314		(a)	494,448
Total current liabilities	1,238,644		(4,321)			1,234,323

Long-term debt	2,632,072		$	—		2,632,072
Long-term liabilities	800,859		(34,730)		(a), (b)	766,129
Operating lease liabilities	142,276		(3,140)		(a)	139,136

Total liabilities	4,813,851		(42,191)			4,771,660

Total stockholders' equity	7,182,739		(142,495)		(a), (b)	7,040,244
Total liabilities and stockholders' equity	$	11,996,590	$	(184,686)		$	11,811,904


PREPARED IN ACCORDANCE WITH GAAP


	Three Months Ended April 5, 2026							Three Months Ended March 30, 2025
(In thousands, except per share data)	Historical		Disposition and Pro Forma Adjustments			Pro Forma		Historical		Disposition and Pro Forma Adjustments			Pro Forma

Revenue	$	711,118	$	(24,206)	(c)	$	686,912	$	664,762	$	(36,064)	(c)	$	628,698

Cost of revenue	323,463		(14,297)		(c)	309,166		289,216		(17,839)		(c)	271,377
Selling, general and administrative expenses	253,882		(14,106)		(c)	239,776		249,719		34,004		(c), (d)	283,723
Research and development expenses	57,887		—			57,887		53,597		—			53,597

Operating income from continuing operations	75,886		4,197			80,083		72,230		(52,229)			20,001

Interest income	(6,304)		10		(c)	(6,294)		(10,081)		13		(c)	(10,068)
Interest expense	24,718		—			24,718		22,964		—			22,964
Change in fair value of investments	4,204		—			4,204		(3,073)		—			(3,073)
Other expense, net	3,276		(711)		(c)	2,565		10,038		(611)		(c)	9,427

Income from continuing operations, before income taxes	49,992		4,898			54,890		52,382		(51,631)			751

Provision for income taxes	9,099		501		(c)	9,600		10,713		6,196		(c), (d)	16,909

Income from continuing operations	40,893		4,397			45,290		41,669		(57,827)			(16,158)

(Loss) income from discontinued operations	(175)		—			(175)		568		—			568

Net income	$	40,718	$	4,397		$	45,115	$	42,237	$	(57,827)		$	(15,590)

Diluted earnings per share:
Income from continuing operations	$	0.37				$	0.40	$	0.35				$	(0.13)

(Loss) income from discontinued operations	(0.00)					(0.00)		0.00					0.00

Net income	$	0.36				$	0.40	$	0.35				$	(0.13)

Weighted average diluted shares of common stock outstanding	111,876					111,876		120,233					120,233


ABOVE PREPARED IN ACCORDANCE WITH GAAP


	Twelve Months Ended December 28, 2025
(In thousands, except per share data)	Historical		Disposition and Pro Forma Adjustments			Pro Forma

Revenue	$	2,856,051	$	(164,552)	(c)	$	2,691,499

Cost of revenue	1,291,686		(99,558)		(c)	1,192,128
Selling, general and administrative expenses	991,890		(14,301)		(c), (d)	977,589
Research and development expenses	215,840		—			215,840

Operating income from continuing operations	356,635		(50,693)			305,942

Interest income	(31,103)		76		(c)	(31,027)
Interest expense	92,185		—			92,185
Change in fair value of investments	11,456		—			11,456
Other expense, net	15,820		(2,765)		(c)	13,055

Income from continuing operations, before income taxes	268,277		(48,004)			220,273

Provision for income taxes	28,394		2,307		(c), (d)	30,701

Income from continuing operations	239,883		(50,311)			189,572

Income from discontinued operations	1,318		—			1,318

Net income	$	241,201	$	(50,311)		$	190,890

Diluted earnings per share:
Income from continuing operations	$	2.06				$	1.63

Income from discontinued operations	0.01					0.01

Net income	$	2.07				$	1.64

Weighted average diluted shares of common stock outstanding	116,595					116,595


ABOVE PREPARED IN ACCORDANCE WITH GAAP